Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | RVMD | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 280.11 | 901.11 | 160.65 | ||
| High | 282.98 | 902.89 | 164.78 | ||
| Low | 273.11 | 863.96 | 158.40 | ||
| Latest | 278.09 | 877.72 | 162.99 | ||
| Change | -4.63 | -14.54 | +5.22 | ||
| % Change | -1.64% | -1.63% | +3.31% | ||
| Volume | 2,204,700 | 351,900 | 4,702,500 | ||
| 20-Day Average Volume | 1,169,575 | 326,190 | 2,988,025 | ||
| Previous Close | 282.72 | 892.26 | 157.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 293.05 | 853.25 | 154.20 | ||
| 20-Day Raw Stochastic | 13.31% | 71.22% | 85.99% | ||
| 20-Day Relative Strength | 40.48 | 57.66 | 60.90 | ||
| Weighted Alpha | -23.37 | +51.89 | +151.51 | ||
| Today's Opinion | 100% Sell | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Sell | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.90% since 06/11/26 | -2.36% since 06/11/26 | +9.22% since 06/11/26 | ||
| Low | 273.11 on 06/18/26 | 863.96 on 06/18/26 | 149.67 on 06/12/26 | ||
| High | 291.28 on 06/12/26 | 911.88 on 06/12/26 | 164.78 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | -2.86% since 05/18/26 | +13.07% since 05/18/26 | +12.90% since 05/18/26 | ||
| Low | 273.11 on 06/18/26 | 775.62 on 05/19/26 | 141.44 on 06/10/26 | ||
| High | 310.53 on 06/04/26 | 911.88 on 06/12/26 | 166.50 on 06/01/26 | ||
| 3-Month | |||||
| %Chg | -11.66% since 03/18/26 | +28.18% since 03/18/26 | +66.13% since 03/18/26 | ||
| Low | 273.11 on 06/18/26 | 661.85 on 03/20/26 | 91.52 on 03/30/26 | ||
| High | 343.36 on 04/14/26 | 911.88 on 06/12/26 | 166.50 on 06/01/26 | ||
| 6-Month | |||||
| %Chg | -29.78% since 12/18/25 | +3.62% since 12/18/25 | +114.57% since 12/18/25 | ||
| Low | 273.11 on 06/18/26 | 661.85 on 03/20/26 | 76.28 on 01/05/26 | ||
| High | 427.05 on 01/07/26 | 911.88 on 06/12/26 | 166.50 on 06/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 37,128,632 | 54,583,640 | 34,651,024 | ||
| Shares Outstanding, K | 133,513 | 62,188 | 212,596 | ||
| Annual Sales | 3,713,940,000 | 4,248,050,000 | 0 | ||
| Annual Net Income | 313,750,000 | 1,292,040,000 | -1,131,300,000 | ||
| Last Quarter Sales | 1,167,180,000 | 1,313,000,000 | 0 | ||
| Last Quarter Net Income | 205,990,000 | 366,000,000 | -453,820,000 | ||
| 60-Month Beta | 0.29 | 0.47 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 04/30/26 | 5.52 on 05/07/26 | -2.29 on 05/06/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 77.46 | 39.73 | 0.00 | ||